Research ExplorerPublicationsNondetected tumor (pT0) after prolonged, neoadjuvant treatme...

Nondetected tumor (pT0) after prolonged, neoadjuvant treatment of localized prostatic carcinoma.

Standard

Nondetected tumor (pT0) after prolonged, neoadjuvant treatment of localized prostatic carcinoma. / Köllermann, Jens; Feek, U; Müller, H; Kaulfuss, U; Oehler, U; Helpap, B; Köllermann, M W.

In: EUR UROL, Vol. 38, No. 6, 6, 2000, p. 714-720.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Köllermann, J, Feek, U, Müller, H, Kaulfuss, U, Oehler, U, Helpap, B & Köllermann, MW 2000, 'Nondetected tumor (pT0) after prolonged, neoadjuvant treatment of localized prostatic carcinoma.', EUR UROL, vol. 38, no. 6, 6, pp. 714-720. <http://www.ncbi.nlm.nih.gov/pubmed/11111189?dopt=Citation>

APA

Köllermann, J., Feek, U., Müller, H., Kaulfuss, U., Oehler, U., Helpap, B., & Köllermann, M. W. (2000). Nondetected tumor (pT0) after prolonged, neoadjuvant treatment of localized prostatic carcinoma. EUR UROL, 38(6), 714-720. [6]. http://www.ncbi.nlm.nih.gov/pubmed/11111189?dopt=Citation

Vancouver

Köllermann J, Feek U, Müller H, Kaulfuss U, Oehler U, Helpap B et al. Nondetected tumor (pT0) after prolonged, neoadjuvant treatment of localized prostatic carcinoma. EUR UROL. 2000;38(6):714-720. 6.

Bibtex

@article{83a56ef64f4f4c16b6d0e97a996fcdc5,
title = "Nondetected tumor (pT0) after prolonged, neoadjuvant treatment of localized prostatic carcinoma.",
abstract = "OBJECTIVES: 135 patients with stage T1-3N0M0 prostatic carcinoma were submitted to prolonged PSA-monitored neoadjuvant endocrine treatment (PPNET). The rate of pT0 reports was three times higher (15%) than after the standard 3-month therapy (5%). The present work was done to elucidate the initial characteristics of these tumors, to see if additional workup of these prostatectomy specimens is able to detect tumor vestiges and, if so, to describe their morphology. METHODS: The original clinical and histopathological data of 20 pT0 cases were reviewed and an additional histopathological workup of the prostatectomy specimens was done. RESULTS: The majority of patients had initially small (9 patients cT1, 8 patients cT2, 3 patients cT3) and well-differentiated tumors (18 patients Gleason score",
author = "Jens K{\"o}llermann and U Feek and H M{\"u}ller and U Kaulfuss and U Oehler and B Helpap and K{\"o}llermann, {M W}",
year = "2000",
language = "Deutsch",
volume = "38",
pages = "714--720",
journal = "EUR UROL",
issn = "0302-2838",
publisher = "Elsevier",
number = "6",

}

RIS

TY - JOUR

T1 - Nondetected tumor (pT0) after prolonged, neoadjuvant treatment of localized prostatic carcinoma.

AU - Köllermann, Jens

AU - Feek, U

AU - Müller, H

AU - Kaulfuss, U

AU - Oehler, U

AU - Helpap, B

AU - Köllermann, M W

PY - 2000

Y1 - 2000

N2 - OBJECTIVES: 135 patients with stage T1-3N0M0 prostatic carcinoma were submitted to prolonged PSA-monitored neoadjuvant endocrine treatment (PPNET). The rate of pT0 reports was three times higher (15%) than after the standard 3-month therapy (5%). The present work was done to elucidate the initial characteristics of these tumors, to see if additional workup of these prostatectomy specimens is able to detect tumor vestiges and, if so, to describe their morphology. METHODS: The original clinical and histopathological data of 20 pT0 cases were reviewed and an additional histopathological workup of the prostatectomy specimens was done. RESULTS: The majority of patients had initially small (9 patients cT1, 8 patients cT2, 3 patients cT3) and well-differentiated tumors (18 patients Gleason score

AB - OBJECTIVES: 135 patients with stage T1-3N0M0 prostatic carcinoma were submitted to prolonged PSA-monitored neoadjuvant endocrine treatment (PPNET). The rate of pT0 reports was three times higher (15%) than after the standard 3-month therapy (5%). The present work was done to elucidate the initial characteristics of these tumors, to see if additional workup of these prostatectomy specimens is able to detect tumor vestiges and, if so, to describe their morphology. METHODS: The original clinical and histopathological data of 20 pT0 cases were reviewed and an additional histopathological workup of the prostatectomy specimens was done. RESULTS: The majority of patients had initially small (9 patients cT1, 8 patients cT2, 3 patients cT3) and well-differentiated tumors (18 patients Gleason score

M3 - SCORING: Zeitschriftenaufsatz

VL - 38

SP - 714

EP - 720

JO - EUR UROL

JF - EUR UROL

SN - 0302-2838

IS - 6

M1 - 6

ER -